Location History:
- Schenectady, NY (US) (1981 - 1991)
- Bel Air, MD (US) (2011 - 2015)
Company Filing History:
12 out of 51,907 
3 out of 1,929 
2 out of 43 
Years Active: 1981-2015
Title: Michael S Adler: Innovator in Organophosphorus Poisoning Treatment
Introduction
Michael S Adler is a notable inventor based in Schenectady, NY (US). He has made significant contributions to the field of medical treatments, particularly in addressing organophosphorus poisoning. With a total of 18 patents to his name, Adler's work has had a profound impact on both veterinary and human medicine.
Latest Patents
Among his latest patents, Adler has developed a method for treating organophosphorus poisoning. This invention focuses on various methods for treating animals at risk of exposure to organophosphorus compounds. The treatment involves administering a therapeutically effective amount of galantamine or its biologically active analogs. Another patent details a method for treating organophosphorus poisoning in mammals, which also includes administering an OP poisoning-inhibiting amount of galantamine.
Career Highlights
Throughout his career, Michael S Adler has worked with prominent companies such as General Electric Company and Pacific Bell. His experience in these organizations has contributed to his innovative approach to solving complex medical issues.
Collaborations
Adler has collaborated with notable individuals in his field, including James E Kohl and Edson X Albuquerque. These partnerships have likely enhanced his research and development efforts.
Conclusion
Michael S Adler's contributions to the treatment of organophosphorus poisoning exemplify his dedication to innovation in medicine. His patents and collaborations reflect a commitment to improving health outcomes for both animals and humans.